Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs Mizuho Financial Group Inc. Sponosred ADR (Japan) (MFG) Price & Performance

Heron Therapeutics IncTrade
Mizuho Financial Group Inc. Sponosred ADR (Japan)Trade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Mizuho Financial Group Inc. Sponosred ADR (Japan) — how do they compare? Heron Therapeutics Inc trades at $0.37 (market cap $74.04M), while Mizuho Financial Group Inc. Sponosred ADR (Japan) trades at $10.41 (market cap $132.18B). The key difference: Mizuho Financial Group Inc. Sponosred ADR (Japan) is far larger — about 1785.3× Heron Therapeutics Inc's market cap, and Mizuho Financial Group Inc. Sponosred ADR (Japan) pays a 1.7% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Mizuho Financial Group Inc. Sponosred ADR (Japan) for 0 Days on average.

HRTXMFG
Market Cap
$74.04M$132.18B
Volume
3,668,0953,264,662
Sector
HealthFinancials
52-Week High
$1.49$11.45
52-Week Low
$0.27$6.09
Typical Hold Time
35 Days0 Days
Enterprise Value
$180.78M$35.48T
Dividend Yield
—1.7%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

HRTX trades at $0.39, up 17.58% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings performance discussions.

The outlook is mixed: strong analyst support and technical momentum suggest potential upside, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on revenue growth translating to profitability, while key risks include execution challenges and competitive pressures in the biotechnology sector.

Mizuho Financial Group Inc. Sponosred ADR (Japan)

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HRTX
8% Buy92% Sell
Avg holding period · 35 Days
MFG
100% Buy0% Sell
Avg holding period · 0 Days

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX →

About Mizuho Financial Group Inc. Sponosred ADR (Japan)

Mizuho Financial Group is a Japanese financial services company offering banking, trust, securities, and asset management services. It serves retail, corporate, and institutional clients globally.

Read more on MFG →